Literature DB >> 34846539

Medial patellofemoral ligament reconstruction for recurrent patellar dislocation allows a good rate to return to sport.

Pierre Meynard1, Matthieu Malatray2, Elliot Sappey-Marinier2, Robert A Magnussen3, Victor Bodiou2, Sébastien Lustig2,4, Elvire Servien2,5.   

Abstract

PURPOSE: Recurrent patellar dislocation is a frequent knee disorders in young, active patients. Medial patellofemoral ligament reconstruction (MPFLR) can restore knee stability and function, but the rate of return to sports is less clear. The aim of this study was to evaluate rate of return to sport following treatment of recurrent patellar dislocation with isolated MPFLR.
METHODS: Between 2011 and 2018, 113 patients with recurrent patellar dislocation were treated with isolated MPFLR at an academic center. Pre-injury sports participation and Tegner score, pre-operative subjective IKDC score, time to return to sports, and post-operative Tegner and subjective IKDC scores were collected, with a minimum of follow-up of 2 years.
RESULTS: One hundred and three patients (91%) were evaluated at a mean of 4.5 ± 2.5-year post-operative. 92 patients (89%) participated in sports prior to onset of patellar instability. At final follow-up, 84 of these 92 patients (91%) were able to return to sports. The mean time from surgery to return to sports was 10.4 ± 8.6 months (range: 2-48 months). 62 patients (67%) returned to the same (50 patients) or higher (12 patients) level. 22 patients (26%) returned at a lower level. 19 of these patients attributed this decreased participation to ongoing knee problems. The median Tegner score was noted to decrease from 5 pre-injury to 4 post-operatively (p = 0.02).
CONCLUSION: Isolated MPFL reconstruction allowed return to pre-injury sports in 91% of patients, with 67% of patients returning to the same or higher level than pre-injury. Mean time to return to sports was 10 months and post-operative Tegner score was noted to be modestly decreased from pre-injury level. LEVEL OF EVIDENCE: IV.
© 2021. The Author(s) under exclusive licence to European Society of Sports Traumatology, Knee Surgery, Arthroscopy (ESSKA).

Entities:  

Keywords:  Isolated medial patellofemoral ligament reconstruction; Medial patellofemoral ligament; Recurrent patellar dislocation; Return to sports; Tegner score

Mesh:

Year:  2021        PMID: 34846539     DOI: 10.1007/s00167-021-06815-1

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  2 in total

1.  Anatomic reconstruction of the medial patellofemoral ligament in children and adolescents using a pedicled quadriceps tendon graft shows favourable results at a minimum of 2-year follow-up.

Authors:  Manfred Nelitz; Jens Dreyhaupt; Sean Robert March Williams
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-06-10       Impact factor: 4.342

2.  Adolescent Medial Patellofemoral Ligament Reconstruction: A Comparison of the Use of Autograft Versus Allograft Hamstring.

Authors:  Nikhil Kumar; Tracey P Bastrom; M Morgan Dennis; Andrew T Pennock; Eric W Edmonds
Journal:  Orthop J Sports Med       Date:  2018-05-24
  2 in total
  3 in total

1.  The coronal alignment technique impacts deviation from native knee anatomy after total knee arthroplasty.

Authors:  Jean-Yves Jenny; Florent Baldairon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-20       Impact factor: 4.114

2.  Mechanically aligned total knee arthroplasty with the extension-first technique does not equally restore neutral knee alignment in all preoperative knee phenotypes.

Authors:  Nina Hörlesberger; Carina Zinggl; Maria Anna Smolle; Lukas Leitner; Birgit Lohberger; Andreas Leithner; Patrick Sadoghi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-10       Impact factor: 4.114

3.  The severity of patellar and trochlear dysplasia are correlated.

Authors:  Victor Meissburger; Grégoire Rougereau; Tristan Langlais; Philippe Boisrenoult; Nicolas Pujol
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-03-26       Impact factor: 4.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.